Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for BioMarin Pharmaceutical in a ...
Zacks Research cut their Q4 2026 earnings per share (EPS) estimates for shares of Ubiquiti in a report issued on Wednesday, ...
Opinion
Zacks Investment Research on MSN4dOpinion
Top Research Reports for Bank of America, Accenture & ServiceNow
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC), ...
Stoke Therapeutics (STOK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
(SAIC) on Monday reported fiscal fourth-quarter net income of $98 million. The Reston, Virginia-based company said it ...
The Swiss National Bank will cut its main policy rate by a quarter percentage point on March 20 to 0.25% and hold it there ...
Last Friday, the three most widely followed benchmark indexes closed a losing week. The S&P 500, the Nasdaq Composite and the ...
Harte-Hanks Inc. (HHS) on Monday reported a loss of $2.4 million in its fourth quarter. On a per-share basis, the ...
DALLAS (AP) — DALLAS (AP) — Sonida Senior Living, Inc. (SNDA) on Monday reported a loss of $5.5 million in its fourth quarter. On a per-share basis, the Dallas-based company said it had a loss of 38 ...
CELEBRATION, Fla. — CELEBRATION, Fla. — Zevra Therapeutics, Inc. (ZVRA) on Tuesday reported a loss of $35.7 million in its fourth quarter. The Celebration, Florida-based company said it had a loss of ...